The Journal of Organic Chemistry
Article
Scheme 3. Synthesis of Dipeptides Using 1-OiPr
(d, J = 17 Hz, 1H), 5.32 (d, J = 11 Hz, 1H), 4.87 (s, 3H), 4.72 (q, J =
6.9 Hz, 2H), 4.62 (d, J = 6.4 Hz, 2H), 4.48−4.40 (m, 2H), 4.10−4.02
(m, 2H), 3.96−3.86 (m, 2H), 3.87−3.77 (m, 2H), 3.52 (s, 3H), 1.49
(t, J = 6.9 Hz, 3H); 13C{1H} NMR (100 MHz, CD3OD): δ 168.5,
166.7, 156.3, 130.8, 120.5, 70.7, 63.3, 61.2, 55.8, 46.9, 14.3; HRMS
(ESI-TOF) calcd for C13H21N4O3 (M − Cl+): 281.1614, found:
281.1629.
Scheme 4. Substitution Reaction of the Condensing
Reagents Using Triethylamine in CD3OD
4-(5-Allyl-6-isopropoxy-4-oxo-4,5-dihydro-1,3,5-triazin-2-yl)-4-
methylmorpholinium chloride (1-OiPr). White solid (876 mg, 88%);
1H NMR (400 MHz, CD3OD): δ 5.92 (ddt, J = 17, 10, 6.0 Hz, 1H),
5.52 (sep, J = 6.4 Hz, 1H), 5.40 (dd, J = 17, 1.4 Hz, 1H), 5.32 (dd, J =
10, 1.4 Hz, 1H), 4.89 (s, 3H), 4.61 (ddd, J = 6.0, 1.4, 1.4 Hz, 2H),
4.47−4.38 (m, 2H), 4.11−4.01 (m, 2H), 3.96−3.86 (m, 2H), 3.86−
3.76 (m, 2H), 3.51 (s, 3H), 1.48 (d, J = 6.4 Hz, 6H); 13C{1H} NMR
(100 MHz, CD3OD): δ 168.6, 166.2, 156.4, 130.8, 120.4, 80.4, 63.3,
61.2, 55.7, 46.9, 21.9; HRMS (ESI-TOF) calcd for C14H23N4O3 (M −
Cl+): 295.1770, found: 295.1788.
4-(5-Allyl-6-(dimethylamino)-4-oxo-4,5-dihydro-1,3,5-triazin-2-
yl)-4-methylmorpholin-4-ium chloride (1-NMe2). White solid (709
mg, 96%); 1H NMR (400 MHz, CD3OD): δ 6.11 (ddt, J = 17, 11, 5.0
Hz, 1H), 5.28−5.41 (m, 2H), 4.56−4.64 (m, 2H), 3.64−4.47 (m,
8H), 3.46 (s, 3H), 3.28 (s, 6H); 13C{1H} NMR (100 MHz, CD3OD):
δ 166.8, 164.8, 159.6, 133.8, 118.4, 63.5, 60.8, 56.1, 52.2, 42.3; HRMS
(FAB-TOF) calcd for C19H19N4O3 ([M + H]+): 351.1457, found:
351.1456.
4.16 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3): δ 170.1, 162.8,
153.8, 129.4, 120.0, 57.9, 45.0; HRMS (DART-TOF) calcd for
C7H9ClN3O2 ([M + H]+): 202.0383, found: 202.0400; anal. calcd for
C7H8ClN3O2: C, 41.70; H, 4.00; N, 20.84. Found: C, 41.62; H, 4.01;
N, 20.83.
1-Allyl-4-chloro-6-ethoxy-1,3,5-triazin-2(1H)-one (12-OEt). Col-
orless oil (451 mg, 84%); 1H NMR (600 MHz, CDCl3): δ 5.85 (ddt, J
= 17, 10, 6.2 Hz, 1H), 5.29 (ddt, J = 17, 1.0, 1.0 Hz, 1H), 5.29 (ddt, J
= 10, 1.0, 1.0 Hz, 1H), 4.61 (q, J = 7.2 Hz, 2H), 4.55 (ddd, J = 6.2,
1.0, 1.0 Hz, 2H), 1.46 (t, J = 7.2 Hz, 3H); 13C{1H} NMR (100 MHz,
CDCl3): δ 170.0, 162.1, 153.8, 129.5, 119.8, 67.9, 44.8, 14.0; HRMS
(DART-TOF) calcd for C8H11ClN3O2 ([M + H]+): 216.0540, found:
216.0527; anal. calcd for C8H10ClN3O2: C, 44.56; H, 4.67; N, 19.49.
Found: C, 44.73; H, 4.71; N, 19.41.
1-Allyl-4-chloro-6-isopropoxy-1,3,5-triazin-2(1H)-one (12-OiPr).
General Procedure for Amidation. To the solution of acid 15c
(48.8 mg, 0.4 mmol), amine 16a (55 μL, 0.44 mmol), and N-
methylmorpholine (48 μL, 0.44 mmol) in MeOH (2 mL) was added
1-OiPr (146 mg, 0.44 mmol) at room temperature. After stirring for
10 min, the reaction mixture was quenched with 1 M aq. KHSO4 and
was concentrated under reduced pressure. The mixture was diluted
with CH2Cl2 and washed with 1 M HCl, sat. aq. NaHCO3, and brine.
The organic layer was dried over Na2SO4, filtered, and concentrated
under reduced pressure. The residue was purified by column
chromatography (hexane/AcOEt 7:3) to afford 17ca (87.5 mg,
97%) as a white solid.
1
White solid (470 mg, 82%); H NMR (400 MHz, CDCl3): δ 5.84
(ddt, J = 17, 11, 6.0 Hz, 1H), 5.48 (sep, J = 6.4 Hz, 1H), 5.28 (ddt, J =
16, 1.4, 1.4 Hz, 1H), 5.28 (ddt, J = 11, 1.4, 1.4 Hz, 1H), 4.53 (ddd, J =
6.0, 1.4, 1.4 Hz, 1H), 1.43 (d, J = 6.4 Hz, 6H); 13C{1H} NMR (100
MHz, CDCl3): δ 170.3, 161.8, 154.1, 129.7, 120.0, 77.0, 44.9, 21.8;
HRMS (DART-TOF) calcd for C9H13ClN3O2 ([M + H]+):
230.0696; found: 230.0713; anal. calcd for C9H12ClN3O2: C, 47.07;
H, 5.27; N, 18.30. Found: C, 46.97; H, 5.30; N, 18.50.
1-Allyl-4-chloro-6-(dimethylamino)-1,3,5-triazin-2(1H)-one (12-
1
NMe2). White solid (1.38 g, 64%); H NMR (600 MHz, CDCl3): δ
6.02 (ddt, J = 17, 11, 5.2 Hz, 1H), 5.31−5.37 (m, 1H), 5.20−5.26 (m,
1H), 4.51−4.55 (m, 2H), 3.17 (s, 6H); 13C{1H} NMR (100 MHz,
CDCl3): δ 168.9, 162.5, 156.2, 131.9, 118.3, 50.3, 41.5; HRMS (ESI+-
TOF) calcd for C8H12ClN4O ([M + H]+): 215.0700, found:
215.0703; anal. calcd for C8H11N4OCl: C, 44.76; H, 5.17; N, 26.10.
Found: C, 44.67; H, 5.15; N, 25.98.
General Procedure for the Synthesis of Condensing
Reagents. To a solution of chlorotriazinone 12-OiPr (689 mg, 3.0
mmol) in Et2O was added N-methylmorpholine (495 μL, 4.5 mmol)
dropwise at 0 °C. After stirring for 1 h, a precipitate was filtered and
washed with Et2O to give 1-OiPr (876 mg, 88% yield) as a white
solid.
N-Phenethyl-3-phenylpropanamide (17aa).1b,4a White solid
1
(96.4 mg, 95%); H NMR (400 MHz, CDCl3): δ 7.30−7.26 (m,
4H), 7.24−7.17 (m, 4H), 7.09 (d, J = 1.8 Hz, 2H), 5.30 (s, 1H), 3.48
(q, J = 4.6 Hz, 2H), 2.95 (t, J = 5.0 Hz, 2H), 2.74 (t, J = 4.6 Hz, 2H),
2.42 (t, J = 5.0 Hz, 2H); 13C{1H} NMR (100 MHz, CDCl3): δ 172.1,
140.9, 140.0, 139.0, 128.8, 128.7, 128.6, 128.5, 126.6, 126.3, 40.7,
38.6, 35.7, 31.8; LRMS (DART-TOF): 254 ([M + H]+).
N,N-Diethyl-3-phenylpropanamide (17ab).1b,4a Colorless oil
1
(70.3 mg, 86%); H NMR (400 MHz, CDCl3): δ 7.32−7.16 (m,
5H), 3.38 (q, J = 7.3 Hz, 2H), 3.22 (q, J = 7.3 Hz, 2H), 2.98 (t, J = 8.3
Hz, 2H), 2.59 (t, J = 8.3 Hz, 2H), 1.11 (t, J = 7.3 Hz, 3H), 1.10 (t, J =
7.3 Hz, 2H); 13C{1H} NMR (100 MHz, CDCl3): δ 171.3, 141.7,
128.5, 126.1, 42.0, 40.3, 35.2, 31.7, 14.3, 13.2; LRMS (DART-TOF):
206 ([M + H]+).
4-(5-Allyl-6-methoxy-4-oxo-4,5-dihydro-1,3,5-triazin-2-yl)-4-
methylmorpholinium chloride (1-OMe). White solid (225 mg,
75%); 1H NMR (400 MHz, CD3OD): δ 5.92 (ddt, J = 17, 11, 6.0 Hz,
1H), 5.41 (ddt, J = 17, 1.4, 1.4 Hz, 1H), 5.32 (ddt, J = 11, 1.4, 1.4 Hz,
1H), 4.62 (ddd, J = 6.0, 1.4, 1.4 Hz, 2H), 4.50−4.40 (m, 2H), 4.26 (s,
3H), 4.10−4.01 (m, 2H), 3.95−3.86 (m, 2H), 3.86−3.76 (m, 2H),
3.51 (s, 3H); 13C{1H} NMR (CD3OD): δ 168.5, 167.4, 156.2, 130.8,
120.4, 63.3, 61.2, 59.7, 55.9, 47.0; HRMS (ESI-TOF) calcd for
C12H19N4O3 ([M − Cl]+): 267.1457, found: 267.1442.
N,N-Dibenzyl-3-phenylpropanamide (17ac).16 White solid (120
mg, 91%); 1H NMR (400 MHz, CDCl3): δ 7.37−7.14 (m, 13H), 7.07
(d, J = 7.4 Hz, 2H), 4.60 (s, 2H), 4.37 (s, 2H), 3.05 (t, J = 7.8 Hz,
2H), 2.72 (t, J = 7.8 Hz, 2H); 13C{1H} NMR (100 MHz, CDCl3): δ
172.8, 141.3, 137.4, 136.5, 129.0, 128.7, 128.6, 128.6, 128.4, 127.7,
127.5, 126.4, 126.2, 49.9, 48.4, 35.1, 31.7; LRMS (DART-TOF): 330
([M + H]+).
4-(5-Allyl-6-ethoxy-4-oxo-4,5-dihydro-1,3,5-triazin-2-yl)-4-meth-
N-Phenethylpivalamide (17ba).4a White solid (66.4 mg, 81%);
1H NMR (600 MHz, CDCl3): δ 7.33−7.16 (m, 5H), 5.66 (brs, 1H),
1
ylmorpholinium chloride (1-OEt). White solid (138 mg, 84%); H
NMR (400 MHz, CD3OD): δ 5.93 (ddt, J = 17, 11, 6.4 Hz, 1H), 5.41
F
J. Org. Chem. XXXX, XXX, XXX−XXX